Generally, asparaginase may be beneficial for malignancies expressing low or no ASNS activity (68, 70, 73, 74), and several studies have investigated the use of asparaginase in non-hematologic malignancies, such as pancreatic, ovarian, and breast cancers (75–79). The gene discussed is ASPG; the disease is breast cancer.